Amos Attali

548 total citations
14 papers, 410 citations indexed

About

Amos Attali is a scholar working on Molecular Biology, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Amos Attali has authored 14 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Neurology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Amos Attali's work include Multiple Sclerosis Research Studies (5 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Amos Attali is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Amos Attali collaborates with scholars based in Netherlands, United Kingdom and Sweden. Amos Attali's co-authors include Theo M. Luider, Tinka Tuinstra, Hans van Aken, Ernst Suidgeest, Laus M. Broersen, Marcel P. Stoop, Nick van Wijk, Johan Garssen, Paula Perez‐Pardo and Aletta D. Kraneveld and has published in prestigious journals such as Nutrients, BMC Bioinformatics and Clinica Chimica Acta.

In The Last Decade

Amos Attali

14 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amos Attali Netherlands	11	206	82	70	63	56	14	410
Mansour Haidar Belgium	15	421 2.0×	47 0.6×	100 1.4×	46 0.7×	171 3.1×	21	766
Itamar Couto Guedes de Jesus Brazil	15	225 1.1×	57 0.7×	78 1.1×	24 0.4×	42 0.8×	39	555
Lisa Hahnefeld Germany	12	229 1.1×	23 0.3×	128 1.8×	30 0.5×	20 0.4×	41	457
Rashmi Ray India	12	250 1.2×	36 0.4×	129 1.8×	63 1.0×	92 1.6×	14	645
Marı̀a Rosa de Sagarra Spain	9	403 2.0×	39 0.5×	60 0.9×	82 1.3×	47 0.8×	11	620
Theodora Panagaki Switzerland	13	168 0.8×	33 0.4×	72 1.0×	21 0.3×	14 0.3×	15	517
Haiyan Wu United States	15	227 1.1×	16 0.2×	64 0.9×	60 1.0×	27 0.5×	32	669
Haiping Wang China	11	292 1.4×	45 0.5×	82 1.2×	17 0.3×	18 0.3×	26	643
Tsuyoshi Takata Japan	12	308 1.5×	34 0.4×	89 1.3×	10 0.2×	15 0.3×	26	551
Yulia E. Kushnareva United States	13	644 3.1×	57 0.7×	117 1.7×	40 0.6×	35 0.6×	13	824

Countries citing papers authored by Amos Attali

Since Specialization

Citations

This map shows the geographic impact of Amos Attali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos Attali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos Attali more than expected).

Fields of papers citing papers by Amos Attali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amos Attali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos Attali. The network helps show where Amos Attali may publish in the future.

Co-authorship network of co-authors of Amos Attali

This figure shows the co-authorship network connecting the top 25 collaborators of Amos Attali. A scholar is included among the top collaborators of Amos Attali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amos Attali. Amos Attali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hendrix, Suzanne, Hilkka Soininen, Anneke M.J. van Hees, et al.. (2019). Alzheimer's Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease. The Journal of Prevention of Alzheimer s Disease. 6(4). 232–236. 8 indexed citations

Scheltens, Nienke M.E., Casper T. Briels, Maqsood Yaqub, et al.. (2019). Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 5(1). 492–500. 3 indexed citations

Perez‐Pardo, Paula, Laus M. Broersen, Nick van Wijk, et al.. (2018). Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson’s Disease. Frontiers in Aging Neuroscience. 10. 237–237. 20 indexed citations

Perez‐Pardo, Paula, Laus M. Broersen, Nick van Wijk, et al.. (2017). Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease. Frontiers in Aging Neuroscience. 9. 57–57. 55 indexed citations

Bruinenberg, Vibeke M., et al.. (2016). A Specific Nutrient Combination Attenuates the Reduced Expression of PSD-95 in the Proximal Dendrites of Hippocampal Cell Body Layers in a Mouse Model of Phenylketonuria. Nutrients. 8(4). 185–185. 10 indexed citations

Smolinska, Agnieszka, Joram M. Posma, Lionel Blanchet, et al.. (2012). Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion. Analytical and Bioanalytical Chemistry. 403(4). 947–959. 23 indexed citations

Stoop, Marcel P., Therese Rosenling, Amos Attali, et al.. (2012). Minocycline Effects on the Cerebrospinal Fluid Proteome of Experimental Autoimmune Encephalomyelitis Rats. Journal of Proteome Research. 11(8). 4315–4325. 18 indexed citations

Coulier, L, Bas Muilwijk, Sabina Bijlsma, et al.. (2012). Metabolite profiling of small cerebrospinal fluid sample volumes with gas chromatography–mass spectrometry: application to a rat model of multiple sclerosis. Metabolomics. 9(1). 78–87. 5 indexed citations

Rosenling, Therese, Marcel P. Stoop, Amos Attali, et al.. (2012). Profiling and Identification of Cerebrospinal Fluid Proteins in a Rat EAE Model of Multiple Sclerosis. Journal of Proteome Research. 11(4). 2048–2060. 47 indexed citations

10.

Blanchet, Lionel, Agnieszka Smolinska, Amos Attali, et al.. (2011). Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis. BMC Bioinformatics. 12(1). 254–254. 65 indexed citations

11.

Rosenling, Therese, Amos Attali, Theo M. Luider, & Rainer Bischoff. (2011). The experimental autoimmune encephalomyelitis model for proteomic biomarker studies: From rat to human. Clinica Chimica Acta. 412(11-12). 812–822. 12 indexed citations

12.

Smolinska, Agnieszka, Amos Attali, Lionel Blanchet, et al.. (2011). NMR and Pattern Recognition Can Distinguish Neuroinflammation and Peripheral Inflammation. Journal of Proteome Research. 10(10). 4428–4438. 19 indexed citations

13.

Noga, Marek, Adrie Dane, Amos Attali, et al.. (2011). Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis. Metabolomics. 8(2). 253–263. 106 indexed citations

14.

Lange, Jos H.M., et al.. (2010). Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(17). 4992–4998. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact